1. A method for preventing and treating COX-2 mediated diseases and conditions comprising administering to a host in need thereof an effective amount of a composition comprising a Free-B-Ring flavonoid or a composition containing a mixture of Free-B-Ring flavonoids and a pharmaceutically acceptable carrier.
2. The method of claim 1 wherein said Free-B-Ring flavonoid is selected from the group of compounds having the following structure:
wherein
R1, R2, R3, R4, and R5 are independently selected from the group consisting of \u2014H, \u2014OH, \u2014SH, \u2014OR, \u2014SR, \u2014NH2, \u2014NHR, \u2014NR2, \u2014NR3+X\u2212, a carbon, oxygen, nitrogen or sulfur, glycoside of a single or a combination of multiple sugars including, aldopentoses, methyl-aldopentose, aldohexoses, ketohexose and their chemical derivatives thereof;
wherein R is an alkyl group having between 1-10 carbon atoms; and
X is selected from the group of pharmaceutically acceptable counter anions including, hydroxyl, chloride, iodide, sulfate, phosphate, acetate, fluoride and carbonate.
3. The method of claim 1 wherein said Free-B-Ring flavonoid is obtained by organic synthesis.
4. The method of claim 1 wherein said Free-B-Ring flavonoid is isolated from a plant part.
5. The method of claim 4 wherein said plant is selected from a family consisting of Annonaceae, Asteraceae, Bignoniaceae, Combretaceae, Compositae, Euphorbiaceae, Labiatae, Lauranceae, Leguminosae, Moraceae, Pinaceae, Pteridaceae, Sinopteridaceae, Ulmaceae and Zingiberacea.
6. The method of claim 4 wherein said plant is selected from a genus consisting Desmos, Achyrocline, Oroxylum, Buchenavia, Anaphalis, Cotula, Gnaphalium, Helichrysum, Centaurea, Eupatorium, Baccharis, Sapium, Scutellaria, Molsa, Colebrookea, Stachys, Origanum, Ziziphora, Lindera, Actinodaphne, Acacia, Derris, Glycyrrhiza, Millettia, Pongamia, Tephrosia, Artocarpus, Ficus, Pityrogramma, Notholaena, Pinus, Ulmus and Alpinia.
7. The method of claim 4 wherein the Free-B-Ring flavonoid is isolated from the plant part selected from the group consisting of stems, stem barks, twigs, tubers, roots, root barks, young shoots, seeds, rhizomes, flowers and other reproductive organs, leaves and other aerial parts.
8. The method of claim 1 wherein the COX-2 mediated disease or condition is selected from the group consisting of menstrual cramps, Systemic Lupus Erythromatosis, psoriasis, chronic tension headache, migraine headaches, inflammatory bowel disease; topical wound and minor inflammation conditions selected from the group consisting of minor abrasions, sunburn and contact dermatitis; and solid cancers.
9. The method of claim 1 wherein the Free-B-Ring flavonoid composition is comprised of 0.01% to 100% of the Free-B-Ring flavanoid.
10. The method of claim 1 wherein the composition is administered in a dosage selected from 0.01 to 200 mgkg of body weight.
11. The method of claim 1 wherein the routes of the administration are selected from the group consisting of oral, topical, suppository, intravenous, and intradermic, intragaster, intramusclar, intraperitoneal and intravenous administration in an appropriate pharmaceutical formula.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. Method executed by a processor for determining the lifetime of a software application associated with audio-video \u201cAV\u201d) data, the AV data comprising a plurality of titles, the method comprising the steps of
1. detecting selection of a first title read from a first storage medium;
2. detecting on the first storage medium a first and a second application associated with the first title, and a first indication relating to the first application and a second indication relating to the second application, wherein the first and second applications are distinct;
3. playing back the first title and executing the first and second applications;
4. upon termination of the first title, terminating the first application if the first indication has a first value, and otherwise continuing the first application, and terminating the second application if the second indication has the first value, and otherwise continuing the second application;
5. upon ejection of the first storage medium, terminating the first application if the first indication has a certain value different from the first value and indicating a disc bound application, and otherwise continuing the first application, and terminating the second application if the second indication has the certain value different from the first value and indicating a disc bound application, and otherwise continuing the second application;
6. detecting insertion of a second storage medium;
7. retrieving data from the second storage medium, the data comprising a third indication and AV data of a second title, the third indication being distinct from the second indication; and
8. continuing the first application if the third indication retrieved from the second storage medium has a certain value, and otherwise terminating the first application, wherein the AV data of the second title are played back without the first application being executed, and continuing the second application if the third indication retrieved from the second storage medium has a certain value, and otherwise terminating the second application, wherein the AV data of the second title are played back without the second application being executed.
2. The method according to claim 1, wherein the at least one of the first and second software application is executed on a device that is connected to the playback device, and the connection between the playback device and the device on which the software application is executed includes control lines for terminating the at least one of the first and second software application.